{"personrec":{"StatusID":1,"PersStatus":null,"Status":"Valid","PersID":34856,"PersName":"Wynendaele, Evelien","PublicFlag":1,"CheckedFlag":0,"Surname":"Wynendaele","Firstname":"Evelien","Initials":"E.","AddressedAs":null,"Function":null,"DateLastModified":{"date":"2023-05-02 10:08:18.393000","timezone_type":1,"timezone":"+00:00"},"PersTitle":null,"PersStatusID":null,"AbstractEnglish":null,"AbstractOtherLang":null,"AbstractLangCode":null,"AbstractLangID":null,"AutID":257443,"ND":"2017-06-14","UD":"2017-06-14"},"loaninfo":null,"pictures":[],"institutes":[{"instituterec":{"OrderNr":1,"Acronym":"DruQuaR","ENFunction":null,"InsIDtmp":13976,"OrigNameLangCode":null,"OrigNameLangID":null,"FullOrigName":null,"InsID":13976,"Function":null,"BeginDay":null,"BeginMonth":null,"BeginYear":null,"Begindate":"","Enddate":"","PIAdrID":null,"AdrID":160140,"Line1":"Ottergemsesteenweg 460","Line2":"9000 Gent","Line3":null,"Line4":null,"Phone":null,"GSM":null,"Email":null,"EnvName":"Belgium","EncAddress":"Ottergemsesteenweg 460, 9000 Gent, Belgium","FullStandardName":"Universiteit Gent; Faculteit Farmaceutische Wetenschappen; Vakgroep Farmaceutische Analyse; Drug Quality and Registration","DirectorFlag":null,"MarineSciFlag":null,"SpecializedFlag":null},"parent":null,"institutes":null,"references":null,"conferences":null,"datasets":null,"persons":null,"pastpers":null,"subpers":null,"projects":null,"urls":null,"pictures":null,"published":null,"affrefs":null,"collections":null,"thesterms":null,"taxterms":null,"geoterms":null,"thestermsFRIS":null,"nXtins":null,"previns":null,"spcols":null,"resmessage":"no id specified","complete":0,"participantrec":null,"peerrevs":null,"urlmaps":null}],"pastins":[],"projects":[],"datasets":null,"references":{"A1":[{"BRefID":382877,"RR":"<b>Cooreman, K.; De Spiegeleer, B.; Van Poucke, C.; Vanavermaete, D.; Delbare, D.; Wynendaele, E.; De Witte, B.</b> (2023). Emerging pharmaceutical therapies of Ascidian-derived natural products and derivatives. <i>Environ. Toxicol. Pharmacol. 102</i>: 104254. <a href=\"https://dx.doi.org/10.1016/j.etap.2023.104254\" target=\"_blank\">https://dx.doi.org/10.1016/j.etap.2023.104254</a>","AutID":555289,"MonDate":null,"AnaDate":2023,"PeerRev":1,"outputType":"1_A1","OpenAcc":1},{"BRefID":323072,"RR":"<b>Janssens, Y.; Wynendaele, E.; Vanden Berghe, W.; De Spiegeleer, B.</b> (2019). Peptides as epigenetic modulators: therapeutic implications. <i>Clinical Epigenetics 11</i>: 101. <a href=\"https://dx.doi.org/10.1186/s13148-019-0700-7\" target=\"_blank\">https://dx.doi.org/10.1186/s13148-019-0700-7</a>","AutID":409674,"MonDate":null,"AnaDate":2019,"PeerRev":1,"outputType":"1_A1","OpenAcc":1},{"BRefID":285676,"RR":"<b>Gevaert, B.; Veryser, L.; Verbeke, F.; Wynendaele, E.; De Spiegeleer, B.</b> (2016). Fish hydrolysates: a regulatory perspective of bioactive peptides. <i>Protein and Peptide Letters 23(12)</i>: 1052-1060. <a href=\"https://dx.doi.org/10.2174/0929866523666161102122637\" target=\"_blank\">https://dx.doi.org/10.2174/0929866523666161102122637</a>","AutID":257443,"MonDate":null,"AnaDate":2016,"PeerRev":1,"outputType":"1_A1","OpenAcc":0}]},"urls":null,"spcols":null,"thesterms":null,"taxterms":null,"pub":1,"newses":{"SesID":85279,"LoginName":"VLIZ2000\\zohrab","LoginID":435,"DD":"2017-06-14"},"updses":{"SesID":85279,"LoginName":"VLIZ2000\\zohrab","LoginID":435,"DD":"2017-06-14"},"urlmaps":[],"resmessage":"no id specified","complete":1}